Track topics on Twitter Track topics that are important to you
The purpose of this study is to determine the safety and tolerability of BMS-820836 after single doses
Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment
BMS-820836, BMS-820836, BMS-820836, BMS-820836, BMS-820836, BMS-820836, BMS-820836, BMS-820836, BMS-820836, Placebo, BMS-820836, BMS-820836
Published on BioPortfolio: 2014-08-27T03:19:50-0400
The purpose of this study is to determine the safety and tolerability of BMS-820836 after multiple doses
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase 'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...